--- title: "The smart medical sector surged in the afternoon, with Thalys and Runda Medical hitting the limit up" type: "News" locale: "en" url: "https://longbridge.com/en/news/237975650.md" description: "The smart medical sector surged in the afternoon, with Thalys and Runda Medical hitting the limit up, while Hongbo Pharmaceutical, Mingde Biological, and Kangtai Medical followed suit" datetime: "2025-04-29T05:09:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/237975650.md) - [en](https://longbridge.com/en/news/237975650.md) - [zh-HK](https://longbridge.com/zh-HK/news/237975650.md) generator: "portal-rs" --- # The smart medical sector surged in the afternoon, with Thalys and Runda Medical hitting the limit up The smart medical sector surged in the afternoon, with Thalys and Runda Medical hitting the limit up, while Hongbo Pharmaceutical, Mingde Biological, and Kangtai Medical followed suit ### Related Stocks - [603108.CN](https://longbridge.com/en/quote/603108.CN.md) - [603716.CN](https://longbridge.com/en/quote/603716.CN.md) - [301230.CN](https://longbridge.com/en/quote/301230.CN.md) - [002932.CN](https://longbridge.com/en/quote/002932.CN.md) - [300869.CN](https://longbridge.com/en/quote/300869.CN.md) ## Related News & Research - [TSU: Surpassed growth targets, scaling as a North American specialty leader with strong U.S. momentum](https://longbridge.com/en/news/298637312.md) - [Eurofins Scientific reports 176 million shares, 362,395,012 voting rights outstanding as of Aug. 31, 2026](https://longbridge.com/en/news/298619523.md) - [FST to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/298591269.md) - [Viromed Medical’s Heike Perbandt, closely associated with managing body member Uwe Perbandt, sells shares for EUR 52,000](https://longbridge.com/en/news/298227013.md) - [Nuritas nomme Kees Kruythoff, ancien président d'Unilever Amérique du Nord, au poste de président du conseil d'administration](https://longbridge.com/en/news/298628927.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**